Bestellinformationen
Produktabbildungen
MEL-1 human ES cells labeled with the ShSCP-5 antibody, Cat. No. MAB4408 (lower, red) and DAPI (upper, blue). Only pluripotent human ES cells are lab...
Anti-ShSCP-5, clone 8H9.3
| Speziesreaktivität | Hauptanwendungen | Wirt | Format | Antikörperart |
|---|---|---|---|---|
| H | IC, WB | Mouse | Purified | Monoclonal Antibody |
Description:
Anti-ShSCP-5, clone 8H9.3
Clone:
8H9.3
Trade Name:
Chemicon (Millipore)
Background Information:
Developed in collaboration with Axordia Ltd./University of Sheffield, Anti-ShSCP-5 is a novel stem cell antibody that recognizes a potentially unique 50 kDa cell surface protein, which has been found to be specifically expressed on undifferentiated human embryonic stem cells and embryonal carcinomas.
Key Applications:
- Immunocytochemistry
- Western Blotting
Species Reactivity:
Human
Species Reactivity Note:
Reacts with human. Reactivity to other species has not been determined.
Usage Statement:
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Molecular Weight:
50 kDa
Stem Cell Type:
Human Embryonic Stem Cells
Stem Cell Workflow Stage:
Characterization
Immunogen:
Whole cells from Shef-5 hES cell line (UK Stem Cell Bank)
Format:
Purified
Presentation:
Purified mouse monoclonal IgG1 with 0.05% sodium azide.
Storage Conditions:
Maintain refrigerated at 2-8°C in undiluted aliquots for up to 1 year from date of receipt.
Host:
Mouse
Isotype:
IgG1
Antibody Category:
Stem Cell Research
Antibody Sub-Category:
Pluripotent & Early Differentiation
Antibody Market:
Stem Cells
Concentration:
1 mg/ml
Antibody Type:
Monoclonal Antibody
Specificity:
This antibody has been shown through Fluorometric Microvolume Assay Technology (FMAT) and immunocytochemistry studies to be positive against Shef-1, Shef-4, Shef-5, Shef-6, and MEL-1 human embryonic stem cell lines, as well as embryonal carcinoma cells. Reactivity with other hES line has not yet been determined.